Document is current
Any future updates will be listed below
-
Authors
Mizrahi, Jonathan D.
Shroff, Rachna T.
- License Information
-
More Information
Article History
First Online: 29 June 2020
Compliance with Ethical Standards
:
: Jonathan D. Mizrahi declares that he has no conflict of interest.Rachna T. Shroff has received research funding from Merck, Exelixis, Halozyme, Pieris, and Taiho, and has served as an advisory board member for Merck, Seattle Genetics, Exelixis, QED Therapeutics, Debiopharm, Agios, and Clovis Oncology.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
